Benitec Biopharma Analysis
Benitec Biopharma is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Benitec Biopharma pink sheet analysis is to determine its intrinsic value, which is an estimate of what Benitec Biopharma is worth, separate from its market price. There are two main types of Benitec Biopharma's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Benitec Biopharma's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Benitec Biopharma's stock to identify patterns and trends that may indicate its future price movements.
The Benitec Biopharma pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Benitec Biopharma is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Benitec Pink Sheet trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Benitec Biopharma's ongoing operational relationships across important fundamental and technical indicators.
Benitec |
Benitec Pink Sheet Analysis Notes
The company has price-to-book (P/B) ratio of 0.3. Some equities with similar Price to Book (P/B) outperform the market in the long run. Benitec Biopharma recorded a loss per share of 0.04. The entity had not issued any dividends in recent years. Benitec Biopharma Limited, a biotechnology company, develops treatments for chronic and life-threatening human diseases based on its gene silencing therapy, DNA-directed RNA interference in Australia and the United States. The company was founded in 1995 and is headquartered in Melbourne, Australia. BENITEC BIOPHARMA operates under Drug ManufacturersSpecialty Generic classification in USA and is traded on BATS Exchange.The quote for Benitec Biopharma is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Benitec Biopharma please contact the company at 61 3 8692 7222 or go to http://www.benitec.com.Benitec Biopharma Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more pink sheets at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Benitec Biopharma's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Benitec Biopharma or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Benitec Biopharma is not yet fully synchronised with the market data | |
| Benitec Biopharma has some characteristics of a very speculative penny stock | |
| Benitec Biopharma has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 3.41 M. Net Loss for the year was (8.6 M) with profit before overhead, payroll, taxes, and interest of 16.46 M. | |
| Benitec Biopharma has accumulated about 11.91 M in cash with (7.24 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05. |
Benitec Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 5.22 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Benitec Biopharma's market, we take the total number of its shares issued and multiply it by Benitec Biopharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Benitec Biopharma to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Stock Screener Now
Stock ScreenerFind equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in industry. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in Benitec Pink Sheet
If you are still planning to invest in Benitec Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Benitec Biopharma's history and understand the potential risks before investing.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |